A Single Center, Open-label Trial of Isavuconazole Prophylaxis Against Invasive Fungal Infection in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (HCT)
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 23 Nov 2018
At a glance
- Drugs Isavuconazole (Primary) ; Isavuconazole (Primary)
- Indications Mycoses
- Focus Therapeutic Use
- 14 Nov 2018 Planned number of patients changed from 100 to 99.
- 14 Nov 2018 Status changed from recruiting to active, no longer recruiting.
- 03 Oct 2018 Planned number of patients changed from 92 to 100.